SKI Market

A+| A| A-|

Indian Indices

Sensex

77,409.98 254.36
( 0.33%)

Global Indices

Nasdaq

51,515.27 -505.40
(-0.97%)

Dow Jones

7,441.22 -91.13
(-1.21%)

Hang Seng

71,050.31 1,148.06
(1.64%)

Nikkei 225

10,505.62 11.41
(0.11%)

Forex

USD-INR

94.55 -0.09
(-0.09%)

EUR-INR

109.66 -0.13
(-0.12%)

GBP-INR

126.84 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Goyal Salt Ltd

Industry : Food - Processing - Indian

BSE Code

ISIN Demat

Book Value()

91840

INE0QFE01017

37.3459868

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GOYALSALT

18.14

205.85

EPS(TTM)

Face Value()

Div & Yield %

6.34

Back

Beta Drugs consolidated net profit declines 4.80% in the December 2025 quarter

Feb 15,2026

Net profit of Beta Drugs declined 4.80% to Rs 8.52 crore in the quarter ended December 2025 as against Rs 8.95 crore during the previous quarter ended December 2024. Sales declined 1.16% to Rs 87.27 crore in the quarter ended December 2025 as against Rs 88.29 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	87.27	88.29	-1
OPM %	19.47	20.90	-
PBDT	14.86	17.55	-15
PBT	10.47	14.31	-27
NP	8.52	8.95	-5

77,409.98 254.36 ( 0.33%)

51,515.27 -505.40 (-0.97%)

7,441.22 -91.13 (-1.21%)

71,050.31 1,148.06 (1.64%)

10,505.62 11.41 (0.11%)

94.55 -0.09 (-0.09%)

109.66 -0.13 (-0.12%)

126.84 -0.25 (-0.20%)

0.59 0.00 (-0.20%)